Introduction
Overweight and obesity are commonly associated with metabolic disorders. 1, 2 Nevertheless, genetic factors influence the lipid level variability. 3 In particular, the apolipoprotein B (apo B) plays a central role in lipid metabolism as the major protein component of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), and serves as the ligand for removal of LDL from the circulation by receptor-mediated endocytosis via the LDL receptor. 4 The apo B gene has a common polymorphism resulting in deletion of three amino acids from the signal peptide. 5 It has been suggested that this polymorphism was functional by affecting apo B secretion and assembly with lipids. 6 In epidemiological studies, the Del allele has been associated with altered lipid levels, mainly increased plasma total and LDL-cholesterol concentrations. [7] [8] [9] [10] [11] [12] [13] [14] A recent meta-analysis has shown that subjects with the Del/Del apoB genotype had higher cholesterol levels and an increased risk of coronary heart disease. 15 Improvements in the metabolic status of overweight patients can be achieved by even moderate weight loss: in particular, favorable changes in lipid profiles are observed. Genetic factors could also be involved in the variability of these changes. 16 The aim of the present study was to assess the effect of apo B signal peptide insertion/deletion (Ins/Del) polymorphism on lipid response to a moderately low-calorie diet in overweight subjects.
Subjects and methods

Subjects
A total of 231 unrelated overweight subjects (146 women and 85 men) were recruited from the Nutrition Department of Bichat Hospital in Paris on the basis of body mass index (BMI)425 kg/m 2 . Diabetic patients and patients using drugs known to modify lipid levels were excluded. All patients were French Caucasians. All subjects gave their informed consent and the protocol was approved by the Bichat Hospital Ethics Committee. They were prescribed a lowcalorie diet with a 25% reduction in their spontaneous energy intake. The spontaneous energy intake was assessed using the dietary history method we have described previously. 17 The patients had a second examination within less than 4 months after the inclusion day (77717 days). Dietary intakes for baseline and intervention diets are given in Table 1 .
Anthropometric measures
Weight and height were measured with the subjects barefooted and lightly clothed. Waist and hip circumferences were measured following the recommendations of the Airlie Conference. 18 The ratio of waist to hip circumferences (WHR) was used as an estimate of regional fat distribution.
Lipid, lipoprotein and apolipoprotein measurements Blood samples were obtained after an overnight fast. Plasma cholesterol and triglycerides were assayed by using commercial test kits (Biotrol, Chennevières-Les Louvres, France: Cholesterol Enzymatique Color, Triglycerides Enzymatique Trinder). VLDL were prepared by ultracentrifugation. A measure of 2 ml of serum was mixed with 1 ml solution containing 0.9% NaCl and centrifuged for 3 h (101C) in a Kontron TFT 45.6 rotor at 45 000 rpm. LDL and high-density lipoproteins (HDL) were determined after precipitation by MgCl 2 and phosphotungstate. 19 Apo AI and apo B were determined by the Laurell method (Apofilm, Hydragel; Sebia, Issy les Moulineaux, France).
DNA analysis
Genomic DNA was prepared from white blood cells by phenol extraction. 20 Insertion/deletion polymorphism was analyzed after amplification of the corresponding region by the polymerase chain reaction (PCR) as described by Visvikis et al. 5 The primers for PCR were obtained from Eurogentec SA (Belgium). The product gives rise to a 93-bp fragment corresponding to the insertion (Ins) allele or an 84-bp fragment corresponding to the deletion (Del) allele. The difference of 9 bp corresponds to the presence or absence of three amino-acids (Leu-Ala-Leu) in the signal peptide of the apo B.
Statistical methods
The effects of the genotypes on the different variables (including the differences after Àbefore diet) were tested by two-way (taking sex into account) ANOVA or ANCOVA. The three genotypes were also coded 0, 1, 2 and this variable was used to test an allele dose effect by linear regression analysis (trend test). Pairwise comparisons between genotypes were performed by the Fisher's least significant difference test. All statistics were performed using the SYSTAT statistical software, version 10.
Results Table 2 summarizes the nonlipid characteristics of the study participants. No difference in these variables was observed according to Ins/Del genotypes in the study population, before and after the dietary intervention. Lipid, lipoprotein and apolipoprotein levels before and after the intervention and according to the Ins/Del polymorphism are shown in Table 3 . On spontaneous diet, LDLcholesterol was higher in patients carrying the Del allele (Ins/ Del þ Del/Del) when compared to subjects with Ins/Ins genotype (P ¼ 0.038). The trend toward a higher LDLcholesterol with the number of Del allele was found significant by linear regression (P ¼ 0.024), indicating a gene dose effect. No sex-genotype interaction was found.
There was a significant effect of the apo B Ins/Del polymorphism on the lowering of total and LDL-cholesterol in response to low-calorie diet (P ¼ 0.001). The homozygous subjects Del/Del reduced their total cholesterol (À12.3%) and LDL-cholesterol (À16.8%) more than subjects with Ins/Del genotype (À4.5% and À4.7%) and Ins/Ins genotype (À1.4% and þ 0.9%). The Del/Del homozygous patients were significantly different from the two other genotypes for total and LDL-cholesterol response to diet ( Table 3 ). The heterozygous genotype Ins/Del was also different from the Ins/Ins genotype for the LDL cholesterol response (Table 3) . This indicates a strong Del allele dose effect on the LDLcholesterol response to the restrictive diet. When adjusted for age, sex, initial LDL-cholesterol, BMI, weight loss and decrease in total energetic and lipid intake, the genotype ApoB polymorphism and LDL cholesterol after diet R Jemaa et al effects on the decrease in LDL cholesterol remained significant (P ¼ 0.003).
Discussion
The Apo B Ins/Del polymorphism has often been studied with regard to lipid levels and atherosclerosis. Our results in this population of obese subjects on spontaneous diet show an increase of the concentration of the LDL-cholesterol with the Del allele, which is in good agreement with most of the studies [7] [8] [9] [10] [11] [12] [13] [14] [15] but not all. [21] [22] [23] Nevertheless, the discrepancies between studies could be due to a different selection of subjects, in particular concerning the BMI, since in the latter studies, [21] [22] [23] subjects are described as 'healthy' or 'normal'.
These discrepancies could arise from interactions with nutritional environment as well, such as that we reported here. Our most striking result is the modulation of the response to restrictive diet by the Ins/Del polymorphism of the apo B gene. Subjects carrying Del allele, particularly the homozygotes, are good responders to restrictive diet regarding LDL-cholesterol, even after adjustment for initial levels. To our knowledge, up to now, no studies have been performed concerning the effect of this polymorphism in obese subjects submitted to energetic restriction. Nevertheless, other dietary changes have been studied and the concentration of apo B in response to high fat diets was higher in Ins/Del subjects than in Ins/Ins subjects. 24 The mechanism explaining the association of Ins/Del polymorphism with plasma lipid variations is not yet well understood. Compared to the Ins allele, the Del allele is characterized by the absence of three amino acids (Leu-AlaLeu), which could lead to alterations in the hydrophobicity of the signal peptide. Indeed, the deletion of the tripeptide in the hydrophobic part of the signal peptide affects, in several models in vitro, 6, 25, 26 the translocation of nascent apo B, its assembly with the lipids and its secretion in VLDL form, particularly in presence of lipids. 25 The spontaneous diet of obese subjects, rich in lipids, may then be associated to a bad assembly and/or a lesser production of VLDL for those carrying the deletion. With a restrictive diet, poor in lipids, the difference between the genotypes might disappear. It has been shown, for the rats, that a bad assembly of VLDL is associated with a direct hepatic production of LDL.
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This might happen in Del obese carriers. Another hypothesis is that, if assembly and secretion in VLDL are defective, lipids (including cholesterol) may accumulate in the cell and then provoke a decrease in the synthesis of LDL-receptors. It has been shown that the stimulation of assembly and secretion of VLDL associate with an increase of the transcription of the LDL-receptor gene in a model of obese mice. 27 Yet, the absence of a significant effect of the Ins/Del polymorphism on the plasma VLDL-TG in our study could be an argument against both these hypotheses. Nevertheless, an effect of the Ins/Del polymorphism on the kinetics of the secretion of VLDL has already been found in absence of a significant effect on plasma triglycerides. 28, 29 Finally, an indirect effect of the Ins/Del polymorphism by linkage disequilibrium with a functional polymorphism cannot be excluded.
Conclusion
In conclusion, overweight subjects carrying the Del allele of the apo B signal peptide polymorphism are predisposed to high LDL-cholesterol levels. Nevertheless, they are good responders to low-calorie diet in terms of LDL-cholesterol and Del/Del carriers would have the greatest benefit from a dietary restriction. Thus, the Del allele could be a variability gene. This demonstrates the importance of the interaction between genes and nutritional environment in the determination of the lipid levels and possibly cardiovascular risk in overweight and obesity. ApoB polymorphism and LDL cholesterol after diet R Jemaa et al
